← Back

Wire · opportunities

VenaSeal Cyanoacrylate Closure Heals 88% of Venous Leg Ulcers in 24-Month Study

Published

5 October 2026

Topic

opportunities

◆ Sectors

Medtech

◆ Source

Read at clinicaltrialvanguard.com →

◆ Verified

Fusion42 · 5 October 2026 · Fusion42 review

The 24-month Spectrum study found that VenaSeal Cyanoacrylate Closure healed 88% of venous leg ulcers, addressing a patient group often excluded from device trials. This significant clinical success suggests new treatment options for managing advanced venous disease.

This Wire brief sits within Fusion42's coverage of Medtech.

◆ ◆ The Wire takeaway

You have a new credible device treatment for severe venous leg ulcers to present to clinicians and patients. This clinical data opens a clear door for faster adoption and competitive positioning in venous disease care.

◆ Coverage

1 source · 5 Oct 2026

◆ Related on Wire

◆ Topics

Medtechvenous-ulcersmedtechclinical-trialvascular-treatmentdevice-success